Comparative Pharmacology
Head-to-head clinical analysis: FLAC versus QNASL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLAC versus QNASL.
FLAC vs QNASL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FLAC (Fluorouracil) is a pyrimidine analog that inhibits thymidylate synthase, blocking DNA synthesis. It is converted to active metabolites (FdUMP, FUTP) that disrupt RNA function and DNA replication.
Beclomethasone dipropionate is a corticosteroid with anti-inflammatory activity. It binds to glucocorticoid receptors, inhibiting inflammatory mediators such as prostaglandins and leukotrienes, and reducing nasal inflammation.
Adults: 40 mg orally twice daily.
1 to 2 sprays (80 mcg/spray) per nostril once daily; maximum 2 sprays/nostril/day.
None Documented
None Documented
2-4 hours; prolonged in renal impairment (up to 12 hours)
The terminal elimination half-life is approximately 8-10 hours in healthy adults, supporting twice-daily administration for systemic effects; however, intranasal administration results in minimal systemic absorption, and local half-life in nasal tissues is not well characterized.
Renal: 70% unchanged; Fecal: 20%; Biliary: 10%
The majority of a dose (approximately 40-50%) is excreted in feces as unchanged drug and metabolites, with about 10-15% excreted in urine as metabolites. Biliary excretion is the primary route of elimination.
Category C
Category C
Corticosteroid
Corticosteroid